vs
Bridger Aerospace Group Holdings, Inc.（BAER）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是Bridger Aerospace Group Holdings, Inc.的1.1倍（$9.1M vs $8.5M），Protalix BioTherapeutics, Inc.净利率更高（-60.3% vs -177.2%，领先116.9%），Bridger Aerospace Group Holdings, Inc.同比增速更快（-45.2% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-78.4M），过去两年Bridger Aerospace Group Holdings, Inc.的营收复合增速更高（24.6% vs -6.7%）
布里杰航空集团控股公司是一家美国航空企业，主营业务为航空消防及野火管理服务，目前已在美国24个州和加拿大2个省提供消防作业支持，服务覆盖北美多林火高发区域，在航空消防领域积累了丰富的实践经验。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
BAER vs PLX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.5M | $9.1M |
| 净利润 | $-15.1M | $-5.5M |
| 毛利率 | -65.1% | 49.4% |
| 营业利润率 | -175.0% | -51.1% |
| 净利率 | -177.2% | -60.3% |
| 营收同比 | -45.2% | -49.9% |
| 净利润同比 | -17.9% | -184.8% |
| 每股收益（稀释后） | $-0.26 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $8.5M | $9.1M | ||
| Q3 25 | $67.9M | $17.9M | ||
| Q2 25 | $30.8M | $15.7M | ||
| Q1 25 | $15.6M | $10.1M | ||
| Q4 24 | $15.6M | $18.2M | ||
| Q3 24 | $64.5M | $18.0M | ||
| Q2 24 | $13.0M | $13.5M | ||
| Q1 24 | $5.5M | — |
| Q4 25 | $-15.1M | $-5.5M | ||
| Q3 25 | $34.5M | $2.4M | ||
| Q2 25 | $308.0K | $164.0K | ||
| Q1 25 | $-15.5M | $-3.6M | ||
| Q4 24 | $-12.8M | $6.5M | ||
| Q3 24 | $27.3M | $3.2M | ||
| Q2 24 | $-10.0M | $-2.2M | ||
| Q1 24 | $-20.1M | — |
| Q4 25 | -65.1% | 49.4% | ||
| Q3 25 | 68.9% | 53.4% | ||
| Q2 25 | 39.2% | 62.5% | ||
| Q1 25 | -10.0% | 19.1% | ||
| Q4 24 | 1.2% | 78.7% | ||
| Q3 24 | 64.3% | 53.4% | ||
| Q2 24 | 24.2% | 29.8% | ||
| Q1 24 | — | — |
| Q4 25 | -175.0% | -51.1% | ||
| Q3 25 | 57.5% | 11.9% | ||
| Q2 25 | 18.0% | 7.5% | ||
| Q1 25 | -64.9% | -41.0% | ||
| Q4 24 | -48.0% | 39.6% | ||
| Q3 24 | 50.9% | 22.2% | ||
| Q2 24 | -36.5% | -18.0% | ||
| Q1 24 | -278.0% | — |
| Q4 25 | -177.2% | -60.3% | ||
| Q3 25 | 50.8% | 13.2% | ||
| Q2 25 | 1.0% | 1.0% | ||
| Q1 25 | -99.3% | -35.8% | ||
| Q4 24 | -82.4% | 35.6% | ||
| Q3 24 | 42.4% | 18.0% | ||
| Q2 24 | -76.7% | -16.4% | ||
| Q1 24 | -364.8% | — |
| Q4 25 | $-0.26 | $-0.06 | ||
| Q3 25 | $0.37 | $0.03 | ||
| Q2 25 | $-0.12 | $0.00 | ||
| Q1 25 | $-0.41 | $-0.05 | ||
| Q4 24 | $-0.24 | $0.10 | ||
| Q3 24 | $0.31 | $0.03 | ||
| Q2 24 | $-0.33 | $-0.03 | ||
| Q1 24 | $-0.55 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.4M | $14.7M |
| 总债务越低越好 | $222.5M | — |
| 股东权益账面价值 | $-342.6M | $48.2M |
| 总资产 | $330.3M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $31.4M | $14.7M | ||
| Q3 25 | $55.1M | $13.6M | ||
| Q2 25 | $17.0M | $17.9M | ||
| Q1 25 | $22.3M | $19.5M | ||
| Q4 24 | $39.3M | $19.8M | ||
| Q3 24 | $33.3M | $27.4M | ||
| Q2 24 | $8.5M | $23.4M | ||
| Q1 24 | $6.8M | — |
| Q4 25 | $222.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $208.4M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-342.6M | $48.2M | ||
| Q3 25 | $-322.4M | $52.9M | ||
| Q2 25 | $-351.0M | $49.9M | ||
| Q1 25 | $-347.4M | $45.2M | ||
| Q4 24 | $-326.7M | $43.2M | ||
| Q3 24 | $-304.4M | $32.4M | ||
| Q2 24 | $-328.0M | $28.6M | ||
| Q1 24 | $-348.7M | — |
| Q4 25 | $330.3M | $82.3M | ||
| Q3 25 | $311.0M | $82.3M | ||
| Q2 25 | $279.0M | $78.5M | ||
| Q1 25 | $275.6M | $73.9M | ||
| Q4 24 | $290.8M | $73.4M | ||
| Q3 24 | $307.3M | $61.6M | ||
| Q2 24 | $281.7M | $91.5M | ||
| Q1 24 | $252.4M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.0M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $-78.4M | $1.6M |
| 自由现金流率自由现金流/营收 | -917.3% | 17.8% |
| 资本支出强度资本支出/营收 | 823.4% | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-64.2M | $-13.6M |
8季度趋势，按日历期对齐
| Q4 25 | $-8.0M | $2.0M | ||
| Q3 25 | $41.0M | $-3.7M | ||
| Q2 25 | $1.4M | $-5.2M | ||
| Q1 25 | $-17.7M | $-5.1M | ||
| Q4 24 | $54.5M | $4.0M | ||
| Q3 24 | $200.0K | $4.1M | ||
| Q2 24 | $-22.6M | $-3.6M | ||
| Q1 24 | $-22.8M | — |
| Q4 25 | $-78.4M | $1.6M | ||
| Q3 25 | $34.6M | $-4.2M | ||
| Q2 25 | $515.0K | $-5.7M | ||
| Q1 25 | $-21.0M | $-5.4M | ||
| Q4 24 | $53.5M | $3.6M | ||
| Q3 24 | $-951.0K | $4.0M | ||
| Q2 24 | $-23.6M | $-3.8M | ||
| Q1 24 | $-23.7M | — |
| Q4 25 | -917.3% | 17.8% | ||
| Q3 25 | 51.0% | -23.7% | ||
| Q2 25 | 1.7% | -36.2% | ||
| Q1 25 | -134.0% | -53.0% | ||
| Q4 24 | 343.5% | 19.6% | ||
| Q3 24 | -1.5% | 22.4% | ||
| Q2 24 | -181.3% | -28.1% | ||
| Q1 24 | -430.7% | — |
| Q4 25 | 823.4% | 4.4% | ||
| Q3 25 | 9.3% | 2.8% | ||
| Q2 25 | 3.0% | 2.8% | ||
| Q1 25 | 21.2% | 3.0% | ||
| Q4 24 | 6.3% | 2.3% | ||
| Q3 24 | 1.8% | 0.5% | ||
| Q2 24 | 7.6% | 1.3% | ||
| Q1 24 | 17.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | -1.58× | ||
| Q2 25 | 4.68× | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | 0.01× | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BAER
暂无分部数据
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
